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MinireviewPhoxy Lipids: Revealing PX Domains
as Phosphoinositide Binding Modules
Vam7p, and the sorting nexin, SNX3, are shown to func-
tion as D3-phosphorylated phosphoinositide binding
modules (Cheever et al. 2001; Ellson et al., 2001; Kanai
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and Jack E. Dixon1
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University of Michigan Medical School and et al., 2001; Xu et al. 2001). Moreover, the solution struc-
ture of the p47phox PX domain published in Nature Struc-Life Sciences Institute
Ann Arbor, Michigan 48109 tural Biology offers intriguing insights into possible
mechanisms for the regulation of PX domain function
(Hiroaki et al., 2001). This review will focus on structural
and functional insights into the PX domain as a novelThe coordination of cellular signaling events requires
phosphoinositide binding module.both spatial and temporal regulation. A recurring theme
PX Domains as Regulators of Membraneamong eukaryotic organisms is the use of phosphoinosi-
and Protein Traffickingtide-specific binding domains to direct proteins to dis-
The mechanisms underlying membrane trafficking andcrete sites within cells where their function(s) are re-
vesicular fusion have been intensively studied using thequired. To date, a number of distinct, highly conserved
vacuolar sorting pathway of the budding yeast, Sacchar-phosphoinositide binding motifs have been identified,
omyces cerevisiae, as a model system. Vam7p, athe most well-characterized of which include the C2
PX-containing protein that is an essential component of(PKC conserved region 2), ENTH (epsin N-terminal ho-
vacuolar sorting, is related to the SNAP-23/25 mamma-mology) (Ford et al., 2001; Itoh et al., 2001), FYVE (Fab1,
lian t-SNAREs (Schultz et al., 2000). SNARE proteins,YOTB, Vac1, and EEA1), and PH (pleckstrin homology)
which are found on both cytoplasmic donor vesiclesdomains (Schultz et al., 2000; see references in reviews
(v-SNAREs) and the acceptor organelles to which theyby Gillooly et al. 2001; Hurley and Meyer, 2001; and
are targeted (t-SNAREs), serve to modulate the specific-Odorizzi et al., 2000). These domains recruit proteins to
ity of docking and fusion between donor and acceptorspecific regions in cells via their interactions with inositol
membranes. Vam7p has an N-terminal PX domain, alipids and may also serve as allosteric regulators of
C-terminal coiled-coil t-SNARE motif (Schultz et al.,enzyme activity or protein-protein interactions.
2000), and localizes to the vacuolar membrane as partThe PX domain was initially identified as a conserved
of a vacuolar SNARE complex (Sato et al., 1998; Unger-motif of 130 residues within the p40phox and p47phox
mann and Wickner, 1998). Vam7p has previously beensubunits of the neutrophil NADPH oxidase superoxide
shown to physically interact with Vam3p, which alsogenerating complex (Ponting, 1996). The PX motif can
localizes to vacuolar membranes (Sato et al., 1998; Un-also be found in a wide variety of proteins involved in
germann and Wickner, 1998). Mutation of conservedcell signaling pathways (phospholipases D1 and D2, PI
residues within the Vam7p PX domain create synthetic3-kinase, and Spo14p), vesicular trafficking and yeast
vacuolar sorting defects when combined with a temper-vacuolar morphology (human sorting nexins; yeast
ature-sensitive vam3 allele, suggesting that the PX do-Vps5p, Vps17p, Vam7p, and Mvp1p), and control of
main is necessary for Vam7p function (Sato et al., 1998).yeast bud emergence and cell polarity (Bem1p and
Further, Vam7p does not contain known membrane tar-Bem3p) (Ponting, 1996). Currently, at least 57 human
geting motifs, prompting the question of how it associ-and 15 yeast proteins that contain PX domains have
ates with vacuolar membranes. In an effort to identifybeen identified (Schultz et al., 2000).
the role of the PX domain of Vam7p in vacuolar sorting,Although the function of PX domains has remained
Cheever and colleagues have investigated whether itunclear, previous studies have implied a possible role
may serve as a targeting module to direct the localizationin regulating the subcellular localization of their corre-
of Vam7p (Cheever et al., 2001).sponding proteins. For example, a significant number
In this report, several lines of evidence corroborateof PX proteins are localized to membranes or vesicular
that the PX domain functions to localize Vam7p to vacu-structures within cells (Schultz et al., 2000). In the case
olar membranes (Cheever et al., 2001). First, either a PXof the NADPH oxidase complex, translocation from the
domain point mutation or deletion results in mislocaliza-cytosol to membranes occurs upon activation of the
tion of Vam7p to the cytoplasm. Because a Vam7p mu-neutrophil respiratory burst response (see references
tant lacking the C-terminal coiled-coil motif required forin Babior, 1999). In addition, many of the PX proteins
its interaction with Vam3p still localizes to the vacuolarinvolved in membrane trafficking processes do not con-
membrane, the authors conclude that the PX domaintain recognizable membrane targeting motifs (Schultz
alone is both necessary and sufficient to direct mem-et al., 2000). Taken together, these observations have
brane targeting of Vam7p. It is of note that a Vam7pprovided a strong rationale for investigating whether PX
mutant localizes to endosomes in a yeast strain in whichdomains might function as membrane targeting mod-
endosome-to-vacuole sorting is blocked (vps4). Here,ules. In a series of papers in Nature Cell Biology this
they further observe that this localization is similar tomonth, the PX domains of the NADPH oxidase compo-
that of FYVE-domain-containing proteins, which arenents, p40phox and p47phox, the yeast vacuolar SNARE,
known to target the membrane phosphoinositide, PI(3)P
(see references in reviews by Gillooly et al. 2001; Hurley1 Correspondence: jedixon@umich.edu
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that the PX domain might utilize a similar targeting
mechanism.
In support of this hypothesis, Cheever et al. demon-
strate that a recombinant Vam7p-PX domain protein
specifically binds to PI(3)P in a protein-lipid overlay
assay. VPS34 encodes the sole PI 3-kinase found in
budding yeast and PI(3)P is depleted in vps34 null mu-
tant strains or vps34 temperature-sensitive yeast grown
at the nonpermissive temperature. The mislocalization
of Vam7p observed in yeast harboring vps34 null or
temperature-sensitive mutations provides further evi-
dence of the requirement for PI(3)P in targeting Vam7p
to vacuolar membranes.
Analysis of the Vam7p-PX domain by NMR spectros-
copy has identified several structural elements neces-
sary for its membrane targeting function and interaction
with PI(3)P (Cheever et al., 2001). Specifically, binding
of PI(3)P involves five basic regions and induces confor-
mational changes, which suggests that the PX domain
may form a pocket of positive charge into which the
phosphorylated head group of phosphoinositide is in-
serted. In addition, the side chains of charged and hy-
Figure 1. Model of Phosphoinositide and SH3:PxxP Interactions fordrophobic residues in a loop region preceding the 2
PX Domain-Containing Proteins Involved in Targeted Membrane
helix are predicted to interact with both the surface and Assembly of the Phagocyte NADPH Oxidase
interior of a lipid bilayer. Together, the basic binding Selected regions of NADPH oxidase subunits gp91phox, p22phox,
pocket and membrane attachment loop are likely to p40phox, p67phox, p47phox, and p21Rac1/2 are schematically represented
as follows: phox domain, PX (red); src-homology 3 domain, SH3;contribute significantly to the binding specificity and
proline-rich motif, PxxP (yellow); tetratricopeptide repeat, TPR;targeting function of the Vam7p PX domain. Collectively,
phosphorylation site, P. Specific phosphoinositides (orange) are de-these findings demonstrate that the PX domain of
picted within a lipid bilayer. Blue arrows denote SH3:PxxP interac-
Vam7p is a PI(3)P-specific phosphoinositide binding tions previously identified for p47phox. Red and gold arrows indicate
motif that plays a key role in regulating the subcellular lipid and protein interactions involving p40phox- and p47phox-PX do-
localization and vacuolar sorting function of Vam7p in mains, as described in the text.
yeast.
Further support for the role of the PX domain as a
PX Domains Target Membrane Translocation
phosphoinositide binding/targeting module has been
of NADPH Oxidase Components
provided by Xu and colleagues in their analysis of the
In neutrophils and other professional phagocytic cells,
human sorting nexin, SNX3 (Xu et al., 2001). Sorting
NADPH oxidase catalyzes the production of superoxide
nexins are found in a variety of organisms from yeast (O2) as a precursor to other reactive oxygen speciesto human and function as regulators of protein trafficking (for example, hydrogen peroxide), which function to kill
(see references in Kurten et al., 1996 and Haft et al., invading microorganisms (Babior, 1999). Generation of
1998). Although the exact mechanism by which they O2 is important to pathogen removal and genetic loss,
function has remained unclear, sorting nexins likely tar- or inactivation of individual oxidase subunits results in
get candidate proteins such as growth factor receptors a heightened susceptibility to infection, clinically de-
and vacuolar hydrolases to specific organelles for post- fined as inherited chronic granulomatous diseases
translational processing, recycling, or degradation. In (CGD) (Burg and Pillinger, 2001). Although PX domains
their recent work, Xu et al. show that SNX3 colocalizes were first identified as a region of sequence homology
with the FYVE-domain protein EEA1 (early endosome between the p40phox and p47phox subunits of phagocyte
autoantigen) and internalized transferrin receptor, sug- NADPH oxidase (phox), their role in oxidase function
gesting that it is associated with early endosomes and has remained obscure.
recycling endosomal intermediates. This localization is In their resting state, the subunits of NADPH oxidase
disrupted by the PI 3-kinase inhibitor, wortmannin, indi- are differentially localized to a membrane-bound flavo-
cating that D3-phosphorylated inositol lipids are re- cytochrome b558 (gp91phox and p22phox), or the cytoplasm
quired for proper targeting of SNX3. The authors also (p40phox, p67phox, p47phox, and p21Rac1/2). Upon activation,
show that the PX domain of SNX3, like that of Vam7p, the cytosolic components translocate and become part
binds specifically to PI(3)P. Furthermore, overexpres- of a functional membrane oxidase complex (Figure 1).
sion of SNX3 disrupts trafficking of both transferrin and Because inappropriate O2production can cause dam-
EGF receptors in a manner that is dependent on its age to host tissues, activation of the NADPH oxidase
ability to bind PI(3)P. Together, these findings implicate complex is subject to strict spatial and temporal con-
a role for SNX3 in regulating protein sorting through straints. In unstimulated cells, p40phox, p67phox and p47phox
endosomal pathways and underscore the concept that exist as an inactive cytoplasmic complex held together
targeting to PI(3)P by its PX domain is an essential com- by intra- and intermolecular protein-protein interactions
that must rearrange to permit membrane translocationponent of this regulation.
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and cytochrome activation to occur (Figure 1). Phos-
phorylation appears to modulate at least some of these
protein interactions (Babior, 1999), however, recent
work by two groups provides new insights into the sig-
nals responsible for targeted translocation of the
p40phox:p67phox:p47phox complex to the phagosomal mem-
brane (Ellson et al., 2001; Kanai et al., 2001).
Previous studies have implicated the products of PI
3-kinase in stimulating neutrophil O2 production (see
references in Kanai et al., 2001 and Wymann et al., 2000),
but until recently, their mechanism of action has re-
mained unknown. Using a cell free assay, Ellson and
colleagues report that recombinant PI 3-kinase or its
purified lipid products, PI(3,4,5)P3 or PI(3,4)P2, indepen-
dently stimulate the production of O2 from a mixture of
neutrophil membranes and cytosol. Ellson et al. use
chromatographic fractionation and sequencing of neu-
trophil cytosolic proteins to identify two lipid phospha-
Figure 2. NMR Solution Structure and Putative Functional Regionstases, SHIP-1 and PI(3,4)P2 4-phosphatase type 1, as
of the p47phox-PX Domainwell as a complex of p40phox:p67phox, that are indepen-
Coordinates of the p47phox-PX structure (PDB 1gd5_No1) were kindlydently capable of mediating PI(3,4,5)P3-dependent O2
provided by D. Kohda. Segments of  helical (yellow) and  strandproduction. Because these phosphatases could possi- (green) conformation are indicated. Selected amino acids and re-
bly act to dephosphorylate PI(3,4,5)P3 and PI(3,4)P2 at gions implicated in PX domain functions are provided as described
the D5 and D4 positions, respectively, and catalytic ac- in the text.
tivity is essential for their effects, the authors surmise
that the ultimate PI(3)P product could be the O2gener-
ating signal. Indeed, PI(3)P alone is capable of activat- PI-lipids. Similarly, mutation of p47phox-PX Arg42 to Gln,
ing a relipidated mixture of purified cytochrome b, which mimics an endogenous mutation identified in a
p40phox:p67phox, p47phox, and GTP-rac. Importantly, activa- subset of CGD patients (Noack et al., 2001), or the analo-
tion by PI(3)P requires the presence of p40phox. Moreover, gous mutation of p40phox-PX (Arg57 to Gln), completely
isolated p40phox bound to immobilized lipid vesicles in a abolishes PI-lipid interaction in vitro. In addition, the
PI(3)P-dependent and -specific manner, suggestive of p40phox-PX Arg57 to Gln mutation causes a reduction
a direct protein-lipid interaction. Recombinant versions in the endosomal localization observed with wild-type
of the PX domain of p40phox exhibit lipid vesicle binding p40phox-PX. Although the relative contribution of lipid
but are unable to activate cytochrome b, indicating that binding by either p40phox or p47phox to membrane translo-
the PX domain facilitates PI(3)P-mediated activation in
cation remain to be determined, the Ellson and Kanai
vitro only in the context of full-length p40phox. Finally, as
reports provide a mechanism for targeting the cyto-
seen with the SNX3 protein (Xu et al., 2001), wortmannin
plasmic p40phox:p67phox:p47phox complex to the phagoso-
disrupts the colocalization of p40phox-PX domains with
mal membrane and further establish PI-lipid binding asendosomal EEA1, suggesting that membrane targeting
a general function of the PX domain family.of endogenous p40phox is likely mediated by PX:PI(3)P
SH3 Domain Binding Alters PX Domain Structureinteractions (Figure 1).
Binding of src homology-3 (SH3) domains to proline-richIn a structure-function analysis of the PX domains of
motifs (PxxP) constitutes the major interaction betweenp40phox and p47phox, Kanai et al. demonstrate both the
p47phox and the other NADPH oxidase subunits (FigurePI(3)P-specificity of p40phox-PX interactions in vitro, and
1) (Babior, 1999). In the resting state, intramolecularthe wortmannin-sensitive localization in cultured cells
interactions within p47phox are thought to prohibit its twoas seen by Ellson (Kanai et al., 2001). They also demon-
SH3 domains from binding other oxidase subunits.strate that p40phox-PX colocalization with EEA1 occurs
Mindful of the fact that a majority of known PX domainsat sites of PI(3)P-specific, EEA1-FYVE domain interac-
contain a PxxP motif in the center of their conservedtion. In contrast to p40phox-PX specificity, however, Kanai
sequence (Ponting, 1996), Hiroaki and coworkers sug-et al. also observe p47phox-PX binding with different affin-
gest a new mechanism for regulating p47phox activity.ities toward immobilized D3-phosphorylated inositol lip-
They demonstrate that the PxxP motif within the p47phox-ids in vitro (PI(3,4)P2 PI(3)PPI(3,5)P2 PI(3,4,5)P3).
PX serves as a specific target for the C-terminal p47phox-Moreover, differential binding of p47phox-PX to liposomes
SH3 domain (Figure 1) (Hiroaki et al., 2001). These au-containing either PI(3,4)P2, PI(4,5)P2, or no phosphoino-
thors also determine the NMR solution structure of thesitides indicates that in addition to sites of high affinity
p47phox-PX domain (Figure 2), and show that p47phox-SH3PI-lipid binding, p47phox-PX contains determinants for
binding alters the conformation of the PxxP loop andgeneral membrane interaction as seen in the NMR struc-
hydrophobic contacts between helices in the structuralture of Vam7p (Cheever et al., 2001). In an attempt to
core. These observations suggest that SH3 binding isidentify amino acids critical for PX function, Kanai et al.
a significant aspect of p47phox-PX domain function.have mutated two arginines whose identity or charge
The paper by Hiroaki et al. appeared concomitant withare conserved in the majority of PX-domain-containing
the reports of PI-lipid binding by p47phox-PX (Kanai etproteins (Ponting, 1996). Mutation of p47phox-PX Arg90
to Leu significantly reduces binding to all immobilized al., 2001) and the NMR data from Vam7p-PX (Cheever
Cell
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et al., 2001). Analysis of the collective work on SH3 domain and phosphoinositides will require further study
and phospholipid binding makes it possible to draw to better understand both the specificity of lipid binding
additional insight from the PX domain solution structure. and regulatory mechanisms of PX function.
First, the p47phox-PX structure places the Phe44 and
Selected ReadingArg90 residues in a surface accessible pocket (Figure
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phosphoinositide binding module provides significant
insight into its function in targeting proteins to specific
cellular membranes. In addition, the PX domain struc-
ture-function studies reveal key determinants of its lipid
binding specificity as well as potential mechanisms by
which its function may be regulated. Now that a role
has been ascribed to the PX domain, there are several
interesting aspects of its specificity and regulation
which may be investigated further. For example, what
phosphoinositides are the specific targets of other PX
domain proteins and how might they affect the physio-
logic functions of these proteins? It is clear from the
works reviewed herein that individual PX domains are
capable of recognizing different phosphoinositides,
which will likely effect the localization of PX proteins to
distinct subcellular compartments. Another question of
significant interest is how potential intra- or intermolecu-
lar interactions of the PxxP motif with SH3 domains
affect lipid binding and thus localization of PX domain
proteins. Are lipid binding and SH3 binding mutually
exclusive events or does binding of one of these ligands
enhance interactions with the other? Finally, the role
of residues implicated in interactions between the PX
